(NYSE: ALB) Albemarle's forecast annual revenue growth rate of 7.86% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 5.04%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.23%.
Albemarle's revenue in 2026 is $5,494,583,000.On average, 26 Wall Street analysts forecast ALB's revenue for 2026 to be $732,610,052,012, with the lowest ALB revenue forecast at $626,940,604,716, and the highest ALB revenue forecast at $926,848,422,209. On average, 24 Wall Street analysts forecast ALB's revenue for 2027 to be $757,140,459,420, with the lowest ALB revenue forecast at $605,712,367,536, and the highest ALB revenue forecast at $936,872,867,544.
In 2028, ALB is forecast to generate $822,240,386,772 in revenue, with the lowest revenue forecast at $593,447,163,832 and the highest revenue forecast at $1,178,049,228,839.